483
BioLife Plasma Services, L.P.FDA 483 - BioLife Plasma Services, L.P. - April 22, 2026
Discuss this record with AI
Record Details
An FDA inspection of BioLife Plasma Services, L.P. in Las Vegas, NV, revealed a significant issue with equipment maintenance. The firm failed to maintain plasmapheresis machines used in source plasma collection according to manufacturer specifications. This lapse in maintenance could compromise the proper performance of critical equipment.
Open in Dashboard
ID · db064fac-2055-4f36-9258-f33b78d95ab2